The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM IN BRIEF: Quindell And ValiRx Placings; Noricum Gold Positive Results

Fri, 15th Nov 2013 07:53

LONDON (Alliance News) - The following AIM-listed companies are making headlines on Alliance News Professional at the market open Friday:
----------
Quindell Portfolio Raises GBP200M Through Share Placing
----------
Bglobal Enters Agreement With Future Energy Solutions For Nutech Training
----------
Northbridge Industrial Services Acquires Assets of Oilfield Material Management For USD3M
----------
Armadale Capital To Buy Rest Of Netcom Global; Deal Gives It 80% Interest In Mpokoto Gold Project
----------
London Capital Finance Director Steps Down; Appoints Interim Finance Chief While It Looks For Successor
----------
Physiomics FY Turnover Up 77% To GBP240,000 Vs GBP135,306; Operating Loss Of GBP548,342 Vs GBP577,922; FY Net Loss Of GBP500,571 Vs GBP539,577; Signed A SEDA Structured Equity Deal, Won A Feasibility Grant
----------
Parkmead Group FY Pretax Loss GBP5.3M Vs GBP4.9M; Revenue Up 38% To GBP4.1 Million; FY Total Assets GBP53.4M Vs GBP22.9M; In Advanced Talks With Debt Lenders
----------
Noricum Gold: Results Continue To Reinforce High Grade Nature Of Rotguloden Project ; Visible Gold Intersected In Drill Hole C9; Drilling On-Going Underground; Looks Forward To Further Positives In Near Future
----------
GW Phamaceuticals Orphan Drug Designation Granted For Epidiolex In Dravet Syndrome By FDA
----------
Touchstone Gold Q3 Net Loss USD499,350 Vs USD2.3M; 9-Mo Net Loss USD16.9M Vs USD7.7M
----------
ValiRx To Raises GBP1M Through Share Placing
----------
Doriemus Reorganises Board, Don Strang New Chairman
----------
Frontier IP Makes New Spin-Out Company With Plymouth University; Receives 21% Stake In New Spin-Out Company PulsiV Solar
----------
Matchtech Chairman: Q1 Trading In Line With Board Expectations; Demand For Contract Recruitment Continues To Grow; Seeing First Signs Of Permanent Candidate Confidence Returning; Q1 Net Fee Income Of GBP11.1M, Up 13%; Looks Forward With Confidence To The Year Ahead
----------
Pantheon Resources FY Loss GBP700,095 Vs GBP703,602
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
2 Nov 2021 09:57

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

AIM WINNERS & LOSERS: Warpaint sees profit topping market forecasts

Read more
16 Sep 2021 18:19

IN BRIEF: ValiRx inks evaluation agreement for breast cancer treatment

IN BRIEF: ValiRx inks evaluation agreement for breast cancer treatment

Read more
7 Sep 2021 15:05

EARNINGS UPDATES: ValiRx reports narrowed loss; McBride revenue slips

EARNINGS UPDATES: ValiRx reports narrowed loss; McBride revenue slips

Read more
6 Jul 2021 13:00

ValiRx adds three new patents in first half

(Sharecast News) - Clinical-stage drug development company ValiRx updated the market on its patent portfolio on Tuesday, reporting that it had continued to build its intellectual property position in the first half of the year.

Read more
27 May 2021 20:17

TRADING UPDATES: Brave Bison, Strix Group see strong performances

TRADING UPDATES: Brave Bison, Strix Group see strong performances

Read more
27 May 2021 13:54

ValiRx terminates peptide drug candidate deal

(Sharecast News) - Clinical-stage drug development company ValiRx announced on Thursday that it has ended its agreement over the evaluation of the 'KTH222' peptide as a drug candidate for treating patients with ovarian cancer.

Read more
20 May 2021 16:07

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
28 Apr 2021 15:30

EXECUTIVE CHANGES: Ex-Coca-Cola exec, Cafe Rouge founder for Deliveroo

EXECUTIVE CHANGES: Ex-Coca-Cola exec, Cafe Rouge founder for Deliveroo

Read more
27 Apr 2021 11:32

TRADING UPDATES: Focusrite sales soar; Gaming Realms in Slingo boost

TRADING UPDATES: Focusrite sales soar; Gaming Realms in Slingo boost

Read more
15 Feb 2021 16:04

Physiomics and ValiRx enter new collaboration deal

(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it announced on Monday, superseding the agreement between the two companies, which was announced in September 2011.

Read more
15 Feb 2021 11:05

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

Read more
19 Jan 2021 16:53

IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer

IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer

Read more
10 Nov 2020 17:40

UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter

UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter

Read more
23 Sep 2020 19:09

UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges

UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges

Read more
7 Sep 2020 11:55

ValiRx Loss Narrows In First Half Amid Reduction In Expenses

ValiRx Loss Narrows In First Half Amid Reduction In Expenses

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.